Inverness Counsel’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,462
Closed -$299K 187
2022
Q2
$299K Sell
1,462
-779
-35% -$165K 0.02% 142
2022
Q1
$533K Sell
2,241
-137
-6% -$32.2K 0.02% 122
2021
Q4
$543K Sell
2,378
-136
-5% -$29.9K 0.02% 115
2021
Q3
$486K Sell
2,514
-2,307
-48% -$467K 0.02% 122
2021
Q2
$1.02M Sell
4,821
-141,006
-97% -$29.8M 0.04% 88
2021
Q1
$29.8M Buy
145,827
+144,363
+9,861% +$28.4M 1.23% 31
2020
Q4
$267K Sell
1,464
-11,493
-89% -$1.95M 0.01% 123
2020
Q3
$2.17M Sell
12,957
-82,301
-86% -$13.9M 0.1% 61
2020
Q2
$15.5M Sell
95,258
-50,065
-34% -$8.97M 0.77% 41
2020
Q1
$25.1M Buy
+145,323
New +$28.9M 1.58% 20

Other funds holding CME

Inverness Counsel's CME Position: Q3 2022 in Review

Inverness Counsel sold out of CME Group (CME) in Q3 2022, closing a stake of 1,462 shares — an estimated $299K sold.

Inverness Counsel first reported a position in CME in Q1 2020 and held it in 10 quarters. The position peaked at $29.8M in Q1 2021. 1,146 funds tracked by Wall St. Rank hold CME as of Q3 2022.

  • Inverness Counsel reported no remaining CME Group position as of Q3 2022 after selling out during the quarter.
  • Inverness Counsel sold 1,462 CME Group shares in Q3 2022, an estimated $299K.
  • Inverness Counsel first reported a position in CME Group in Q1 2020 and held it in 10 quarters.
  • Inverness Counsel's CME Group position peaked at $29.8M in Q1 2021.
  • 1,146 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.